Fair value (multi-method)
Four independent methods triangulate what NVO is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$3,050.99
Method range
$16.40 – $3,050.99
median $377.65
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $3,050.99 | +6,231.16% |
| Exit multiple | $710.30 | +1,373.95% |
| Analyst target | $45.00 | -6.62% |
| Graham number | $16.40 | -65.98% |
- Forward DCF$3,050.99
- Exit multiple$710.30
- Analyst target$45.00
- Graham number$16.40
Stock price
$48.19
FCF / share (TTM)
$2.71
3Y FCF CAGR
-10.9%
Fair value @ hist. growth
$23.37
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
-2.0%
per year over your projection horizon
Margin of safety -106.2% vs hist-growth DCF
Historical 3Y CAGR
-10.9%
Your model implies
-2.0%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -11% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | -4.2% | -5.5% | -6.9% | -8.7% | -11.0% |
| 5.5% | -2.9% | -3.9% | -5.2% | -6.6% | -8.4% |
| 6.5% | -0.2% | -1.1% | -2.0% | -3.1% | -4.3% |
| 7.5% | 2.1% | 1.4% | 0.6% | -0.2% | -1.2% |
| 8.5% | 4.2% | 3.6% | 3.0% | 2.3% | 1.5% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.07
Low vs growth
Net debt
$104B
Total debt − cash
Beta
0.36
Vs market benchmark
Frequently asked questions
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.23% TTM
- Dividend Profile3.74% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.